50 ML Panzyga 100 MG/ML Injection

RxCUI
2102460
RxNorm name
50 ML Panzyga 100 MG/ML Injection
Display name
50 ML Panzyga 100 MG/ML Injection
Full name
50 ML Panzyga 100 MG/ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125587PanzygaImmune Globulin Intravenous (Human)-ifas351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PanzygaIMMUNE GLOBULIN INTRAVENOUS (HUMAN)Octapharma USA Inc9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e02025-05-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2102460
PanzygaIMMUNE GLOBULIN INTRAVENOUS (HUMAN)Pfizer Laboratories Div Pfizer Ince2cc5ddf-119e-ade3-79c2-c712cfbee0992025-05-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2102460

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
68a5ee5f-0352-b3ae-3321-c0a22947a31dpanzyga 10 % in 50 ML Injection [PSN] · 50 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] [SBD] · 50 ML Panzyga 100 MG/ML Injection [SY] · Panzyga 10 % per 50 ML Injection [SY]411These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820210215
e2cc5ddf-119e-ade3-79c2-c712cfbee099panzyga 10 % in 50 ML Injection [PSN] · 50 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] [SBD] · 50 ML Panzyga 100 MG/ML Injection [SY] · Panzyga 10 % per 50 ML Injection [SY]410These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508
9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e0panzyga 10 % in 50 ML Injection [PSN] · 50 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] [SBD] · 50 ML Panzyga 100 MG/ML Injection [SY] · Panzyga 10 % per 50 ML Injection [SY]42These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508